Global Transcatheter Heart Valve Therapies Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Transcatheter Heart Valve Therapies market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Transcatheter Heart Valve Therapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transcatheter Heart Valve Therapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Transcatheter Heart Valve Therapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Transcatheter Heart Valve Therapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Transcatheter Heart Valve Therapies include Cardiac Dimensions, Mitralign, NeoChord, Edwards Lifesciences, Hanyu Medical, Abbott and Valgen Medtech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transcatheter Heart Valve Therapies, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Transcatheter Heart Valve Therapies, also provides the sales of main regions and countries. Of the upcoming market potential for Transcatheter Heart Valve Therapies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transcatheter Heart Valve Therapies sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transcatheter Heart Valve Therapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Transcatheter Heart Valve Therapies sales, projected growth trends, production technology, application and end-user industry.


Transcatheter Heart Valve Therapies Segment by Company

Cardiac Dimensions
Mitralign
NeoChord
Edwards Lifesciences
Hanyu Medical
Abbott
Valgen Medtech

Transcatheter Heart Valve Therapies Segment by Type

Replacement Interventional Devices
Restorative Interventional Devices

Transcatheter Heart Valve Therapies Segment by Application

Hospital
Clinic

Transcatheter Heart Valve Therapies Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Heart Valve Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Heart Valve Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Heart Valve Therapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Transcatheter Heart Valve Therapies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Transcatheter Heart Valve Therapies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcatheter Heart Valve Therapies sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Transcatheter Heart Valve Therapies Market by Type
1.2.1 Global Transcatheter Heart Valve Therapies Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Replacement Interventional Devices
1.2.3 Restorative Interventional Devices
1.3 Transcatheter Heart Valve Therapies Market by Application
1.3.1 Global Transcatheter Heart Valve Therapies Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Transcatheter Heart Valve Therapies Market Dynamics
2.1 Transcatheter Heart Valve Therapies Industry Trends
2.2 Transcatheter Heart Valve Therapies Industry Drivers
2.3 Transcatheter Heart Valve Therapies Industry Opportunities and Challenges
2.4 Transcatheter Heart Valve Therapies Industry Restraints
3 Global Market Growth Prospects
3.1 Global Transcatheter Heart Valve Therapies Revenue Estimates and Forecasts (2020-2031)
3.2 Global Transcatheter Heart Valve Therapies Revenue by Region
3.2.1 Global Transcatheter Heart Valve Therapies Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Transcatheter Heart Valve Therapies Revenue by Region (2020-2025)
3.2.3 Global Transcatheter Heart Valve Therapies Revenue by Region (2026-2031)
3.2.4 Global Transcatheter Heart Valve Therapies Revenue Market Share by Region (2020-2031)
3.3 Global Transcatheter Heart Valve Therapies Sales Estimates and Forecasts 2020-2031
3.4 Global Transcatheter Heart Valve Therapies Sales by Region
3.4.1 Global Transcatheter Heart Valve Therapies Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Transcatheter Heart Valve Therapies Sales by Region (2020-2025)
3.4.3 Global Transcatheter Heart Valve Therapies Sales by Region (2026-2031)
3.4.4 Global Transcatheter Heart Valve Therapies Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Transcatheter Heart Valve Therapies Revenue by Manufacturers
4.1.1 Global Transcatheter Heart Valve Therapies Revenue by Manufacturers (2020-2025)
4.1.2 Global Transcatheter Heart Valve Therapies Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Transcatheter Heart Valve Therapies Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Transcatheter Heart Valve Therapies Sales by Manufacturers
4.2.1 Global Transcatheter Heart Valve Therapies Sales by Manufacturers (2020-2025)
4.2.2 Global Transcatheter Heart Valve Therapies Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Transcatheter Heart Valve Therapies Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Transcatheter Heart Valve Therapies Sales Price by Manufacturers (2020-2025)
4.4 Global Transcatheter Heart Valve Therapies Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Transcatheter Heart Valve Therapies Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Transcatheter Heart Valve Therapies Manufacturers, Product Type & Application
4.7 Global Transcatheter Heart Valve Therapies Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Transcatheter Heart Valve Therapies Market CR5 and HHI
4.8.2 2024 Transcatheter Heart Valve Therapies Tier 1, Tier 2, and Tier 3
5 Transcatheter Heart Valve Therapies Market by Type
5.1 Global Transcatheter Heart Valve Therapies Revenue by Type
5.1.1 Global Transcatheter Heart Valve Therapies Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Transcatheter Heart Valve Therapies Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Transcatheter Heart Valve Therapies Revenue Market Share by Type (2020-2031)
5.2 Global Transcatheter Heart Valve Therapies Sales by Type
5.2.1 Global Transcatheter Heart Valve Therapies Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Transcatheter Heart Valve Therapies Sales by Type (2020-2031) & (Units)
5.2.3 Global Transcatheter Heart Valve Therapies Sales Market Share by Type (2020-2031)
5.3 Global Transcatheter Heart Valve Therapies Price by Type
6 Transcatheter Heart Valve Therapies Market by Application
6.1 Global Transcatheter Heart Valve Therapies Revenue by Application
6.1.1 Global Transcatheter Heart Valve Therapies Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Transcatheter Heart Valve Therapies Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Transcatheter Heart Valve Therapies Revenue Market Share by Application (2020-2031)
6.2 Global Transcatheter Heart Valve Therapies Sales by Application
6.2.1 Global Transcatheter Heart Valve Therapies Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Transcatheter Heart Valve Therapies Sales by Application (2020-2031) & (Units)
6.2.3 Global Transcatheter Heart Valve Therapies Sales Market Share by Application (2020-2031)
6.3 Global Transcatheter Heart Valve Therapies Price by Application
7 Company Profiles
7.1 Cardiac Dimensions
7.1.1 Cardiac Dimensions Comapny Information
7.1.2 Cardiac Dimensions Business Overview
7.1.3 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Cardiac Dimensions Transcatheter Heart Valve Therapies Product Portfolio
7.1.5 Cardiac Dimensions Recent Developments
7.2 Mitralign
7.2.1 Mitralign Comapny Information
7.2.2 Mitralign Business Overview
7.2.3 Mitralign Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mitralign Transcatheter Heart Valve Therapies Product Portfolio
7.2.5 Mitralign Recent Developments
7.3 NeoChord
7.3.1 NeoChord Comapny Information
7.3.2 NeoChord Business Overview
7.3.3 NeoChord Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 NeoChord Transcatheter Heart Valve Therapies Product Portfolio
7.3.5 NeoChord Recent Developments
7.4 Edwards Lifesciences
7.4.1 Edwards Lifesciences Comapny Information
7.4.2 Edwards Lifesciences Business Overview
7.4.3 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Edwards Lifesciences Transcatheter Heart Valve Therapies Product Portfolio
7.4.5 Edwards Lifesciences Recent Developments
7.5 Hanyu Medical
7.5.1 Hanyu Medical Comapny Information
7.5.2 Hanyu Medical Business Overview
7.5.3 Hanyu Medical Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Hanyu Medical Transcatheter Heart Valve Therapies Product Portfolio
7.5.5 Hanyu Medical Recent Developments
7.6 Abbott
7.6.1 Abbott Comapny Information
7.6.2 Abbott Business Overview
7.6.3 Abbott Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Abbott Transcatheter Heart Valve Therapies Product Portfolio
7.6.5 Abbott Recent Developments
7.7 Valgen Medtech
7.7.1 Valgen Medtech Comapny Information
7.7.2 Valgen Medtech Business Overview
7.7.3 Valgen Medtech Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Valgen Medtech Transcatheter Heart Valve Therapies Product Portfolio
7.7.5 Valgen Medtech Recent Developments
8 North America
8.1 North America Transcatheter Heart Valve Therapies Market Size by Type
8.1.1 North America Transcatheter Heart Valve Therapies Revenue by Type (2020-2031)
8.1.2 North America Transcatheter Heart Valve Therapies Sales by Type (2020-2031)
8.1.3 North America Transcatheter Heart Valve Therapies Price by Type (2020-2031)
8.2 North America Transcatheter Heart Valve Therapies Market Size by Application
8.2.1 North America Transcatheter Heart Valve Therapies Revenue by Application (2020-2031)
8.2.2 North America Transcatheter Heart Valve Therapies Sales by Application (2020-2031)
8.2.3 North America Transcatheter Heart Valve Therapies Price by Application (2020-2031)
8.3 North America Transcatheter Heart Valve Therapies Market Size by Country
8.3.1 North America Transcatheter Heart Valve Therapies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Transcatheter Heart Valve Therapies Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Transcatheter Heart Valve Therapies Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Transcatheter Heart Valve Therapies Market Size by Type
9.1.1 Europe Transcatheter Heart Valve Therapies Revenue by Type (2020-2031)
9.1.2 Europe Transcatheter Heart Valve Therapies Sales by Type (2020-2031)
9.1.3 Europe Transcatheter Heart Valve Therapies Price by Type (2020-2031)
9.2 Europe Transcatheter Heart Valve Therapies Market Size by Application
9.2.1 Europe Transcatheter Heart Valve Therapies Revenue by Application (2020-2031)
9.2.2 Europe Transcatheter Heart Valve Therapies Sales by Application (2020-2031)
9.2.3 Europe Transcatheter Heart Valve Therapies Price by Application (2020-2031)
9.3 Europe Transcatheter Heart Valve Therapies Market Size by Country
9.3.1 Europe Transcatheter Heart Valve Therapies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Transcatheter Heart Valve Therapies Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Transcatheter Heart Valve Therapies Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Transcatheter Heart Valve Therapies Market Size by Type
10.1.1 China Transcatheter Heart Valve Therapies Revenue by Type (2020-2031)
10.1.2 China Transcatheter Heart Valve Therapies Sales by Type (2020-2031)
10.1.3 China Transcatheter Heart Valve Therapies Price by Type (2020-2031)
10.2 China Transcatheter Heart Valve Therapies Market Size by Application
10.2.1 China Transcatheter Heart Valve Therapies Revenue by Application (2020-2031)
10.2.2 China Transcatheter Heart Valve Therapies Sales by Application (2020-2031)
10.2.3 China Transcatheter Heart Valve Therapies Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Transcatheter Heart Valve Therapies Market Size by Type
11.1.1 Asia Transcatheter Heart Valve Therapies Revenue by Type (2020-2031)
11.1.2 Asia Transcatheter Heart Valve Therapies Sales by Type (2020-2031)
11.1.3 Asia Transcatheter Heart Valve Therapies Price by Type (2020-2031)
11.2 Asia Transcatheter Heart Valve Therapies Market Size by Application
11.2.1 Asia Transcatheter Heart Valve Therapies Revenue by Application (2020-2031)
11.2.2 Asia Transcatheter Heart Valve Therapies Sales by Application (2020-2031)
11.2.3 Asia Transcatheter Heart Valve Therapies Price by Application (2020-2031)
11.3 Asia Transcatheter Heart Valve Therapies Market Size by Country
11.3.1 Asia Transcatheter Heart Valve Therapies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Transcatheter Heart Valve Therapies Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Transcatheter Heart Valve Therapies Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Transcatheter Heart Valve Therapies Market Size by Type
12.1.1 SAMEA Transcatheter Heart Valve Therapies Revenue by Type (2020-2031)
12.1.2 SAMEA Transcatheter Heart Valve Therapies Sales by Type (2020-2031)
12.1.3 SAMEA Transcatheter Heart Valve Therapies Price by Type (2020-2031)
12.2 SAMEA Transcatheter Heart Valve Therapies Market Size by Application
12.2.1 SAMEA Transcatheter Heart Valve Therapies Revenue by Application (2020-2031)
12.2.2 SAMEA Transcatheter Heart Valve Therapies Sales by Application (2020-2031)
12.2.3 SAMEA Transcatheter Heart Valve Therapies Price by Application (2020-2031)
12.3 SAMEA Transcatheter Heart Valve Therapies Market Size by Country
12.3.1 SAMEA Transcatheter Heart Valve Therapies Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Transcatheter Heart Valve Therapies Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Transcatheter Heart Valve Therapies Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Transcatheter Heart Valve Therapies Value Chain Analysis
13.1.1 Transcatheter Heart Valve Therapies Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Transcatheter Heart Valve Therapies Production Mode & Process
13.2 Transcatheter Heart Valve Therapies Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Transcatheter Heart Valve Therapies Distributors
13.2.3 Transcatheter Heart Valve Therapies Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings